Amylyx endocrine drug succeeds in key study for low blood sugar
Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected…
Enveda weight loss maintenance pill mimics exercise in early tests
If you could design an oral treatment that limits appetite and mimics some effects of physical activity, you…
Eli Lilly to offer retatrutide access given earlier to just one patient
Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the…
The VA is critical to winning the biotech race with China
Biotechnology is rapidly becoming a pillar of national power. The nation that can discover, test, and deploy new…
FDA questions the efficacy of Capricor’s Duchenne drug
The Food and Drug Administration said Monday that Capricor Therapeutics’ stem cell treatment for Duchenne muscular dystrophy did…
Measles Is Becoming So Common That Treatments May Soon Be Needed
“I think this is a real opportunity to solve a public health problem,” Saphire says. “A tool by…
Compounded GLP-1s: Why doctors worry and the FDA is cracking down
So, are these copycat versions of the weight loss drugs safe? Poison control centers across the U.S. have…
Rare disease drugmakers seek exclusion from Medicare pricing plans
WASHINGTON — Biotech companies are lobbying the Trump administration to exclude treatments for rare diseases from programs that…
Bristol Myers buys Nvidia’s latest AI computing system for drug research
By Michael Erman NEW YORK, July 20 (Reuters) – Bristol Myers Squibb said on Monday it is buying…
AIDS activists slam Biden R&D deal with Gilead over HIV prevention drug patents
Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He…
Revolution Medicines, Sanofi, Biogen, SSRIs: Readout Newsletter
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…
Pancreatic cancer experts gather to discuss what comes after daraxonrasib
Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially…